恶性瘤耐火性高血症:一个存在许多潜在根源的问题
1Endocrinology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
Frontiers in endocrinology
|June 2, 2023
概括
恶性瘤耐火性高血症 (HCM) 尽管有可用的治疗方法,但仍然存在挑战. 本综述涵盖了HCM驱动因素,机制,当前疗法以及管理这种复杂疾病的未来方向.
科学领域:
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
- 临床医学 临床医学
背景情况:
- 恶性血症 (HCM) 是癌症的常见并发症,严重影响患者的发病率和生活质量.
- 现有的医疗治疗HCM是有效的,但可能会失败在耐火病例,需要替代策略.
- 耐火性HCM的定义是医院出院后不久的重复严重高血症,尽管使用了标准疗法.
研究的目的:
- 阐明恶性瘤高血症背后的主要驱动因素和生理机制.
- 审查当前的治疗选择,针对HCM的特定贡献机制.
- 探索需要进一步调查的耐火性HCM的潜在未来治疗方法.
主要方法:
- 文献综述和综合现有关于HCM的研究.
- 分析导致癌症患者血清水平升高的病理生理路径.
- 讨论HCM管理的既定和新兴治疗方式.
主要成果:
- HCM是由各种因素驱动的,包括幽默因素和骨转移,这些因素通过不同的生理途径提升血清.
- 目前的治疗方法,如双酸盐和denosumab,针对这些机制,但对于耐火病例可能不足.
- 了解HCM的具体驱动因素,可以进行有针对性的治疗干预.
结论:
- 有效管理恶性瘤耐火性高血症需要对其潜在机制有充分的了解.
- 结合现有疗法与新型治疗方法的多方面的方法对于改善耐药性HCM患者的治疗结果至关重要.
- 对新型治疗点的进一步研究对于解决管理这种具有挑战性的瘤并发症的未满足需求至关重要.
关键词:
甲状腺前激素相关蛋白 (PTHrP) 是一种与甲状腺前激素相关的蛋白质.骨质再吸收 骨质再吸收骨的吸收和形成.酸醇是一种酸.这里没有denosumab.恶性瘤的高血症.过高性尿症是一种高性尿症.通过静脉注射的双酸.更多相关视频
08:05A Syngeneic Pancreatic Cancer Mouse Model to Study the Effects of Irreversible Electroporation
Published on: June 8, 2018
11.5K
06:00Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines
Published on: September 13, 2017
7.2K
相关概念视频
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
01:21Skeleton and Calcium Homeostasis
4.6K
Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
4.6K
01:31Osteoclasts in Bone Remodeling
3.0K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.0K
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
210
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
210
01:17Hormones and Bone Tissue
2.8K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.8K
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
256
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
256